-
-
-
-
-
-
-
Morgan Stanley on BioMarin Pharmaceutical Inc. (BMRN): 'we think the settlement recognizes the value of BioMarin’s pioneering CNP innovation'
-
-
-
-
-
-
-
BMO Capital Starts BioMarin Pharmaceutical Inc. (BMRN) at Outperform
-
-
-
-
-
-
-
BioMarin completes acquisition of Amicus Therapeutics
-
-
-
-
-
-
-
Goldman Sachs Starts BioMarin Pharmaceutical Inc. (BMRN) at Neutral
-
-
-
-
-
-
-
BioMarin appoints Ian Clark as board chair, Richard Meier to retire
-
-
-
-
-
-
-
Truist Securities Reiterates Buy Rating on BioMarin Pharmaceutical Inc. (BMRN)
-
-
-
-
-
-
-
BioMarin Pharma (BMRN) Misses Q4 EPS by 31c; offers guidance
-
468,217 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

